LADENBURG THALMANN FINANCIAL SERVICES INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 195 filers reported holding IMMUNOGEN INC in Q4 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2019$35,000
+52.2%
6,367
-34.1%
0.00%
Q3 2019$23,000
+64.3%
9,663
+44.7%
0.00%
Q2 2019$14,000
-44.0%
6,677
-24.9%
0.00%
Q1 2019$25,000
-16.7%
8,886
+40.7%
0.00%
Q4 2018$30,000
-61.5%
6,316
-23.9%
0.00%
-100.0%
Q3 2018$78,000
-17.0%
8,304
-8.1%
0.00%0.0%
Q2 2018$94,0000.0%9,0320.0%0.00%0.0%
Q1 2018$94,000
+70.9%
9,032
+4.8%
0.00%0.0%
Q4 2017$55,000
-14.1%
8,619
+2.3%
0.00%0.0%
Q3 2017$64,000
+77.8%
8,428
+66.4%
0.00%
Q2 2017$36,000
+176.9%
5,065
+50.7%
0.00%
Q1 2017$13,000
+44.4%
3,362
-25.6%
0.00%
Q4 2016$9,000
-43.8%
4,517
-24.9%
0.00%
Q3 2016$16,0000.0%6,016
+12.2%
0.00%
Q2 2016$16,000
-62.8%
5,363
+7.2%
0.00%
-100.0%
Q1 2016$43,000
-44.2%
5,001
-11.2%
0.00%0.0%
Q4 2015$77,000
+220.8%
5,633
+129.8%
0.00%
Q3 2015$24,000
-22.6%
2,451
+12.8%
0.00%
-100.0%
Q2 2015$31,000
+10.7%
2,172
-31.0%
0.00%0.0%
Q1 2015$28,000
-36.4%
3,149
-52.4%
0.00%0.0%
Q4 2014$44,000
+57.1%
6,619
+162.9%
0.00%0.0%
Q3 2014$28,000
+3.7%
2,518
+13.3%
0.00%0.0%
Q2 2014$27,000
-60.3%
2,223
-49.8%
0.00%
-50.0%
Q1 2014$68,000
+19.3%
4,426
+13.6%
0.00%0.0%
Q4 2013$57,000
-44.1%
3,897
-34.9%
0.00%
-33.3%
Q3 2013$102,000
-42.0%
5,982
-43.6%
0.00%
-50.0%
Q2 2013$176,00010,6080.01%
Other shareholders
IMMUNOGEN INC shareholders Q4 2019
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders